ReNeuron Group PLC (RQE)

London
26.00
0.00(0.00%)
  • Volume:
    83,909
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    26.00 - 26.00

RQE Overview

Prev. Close
26
Day's Range
26-26
Revenue
232K
Open
26
52 wk Range
25-135
EPS
-0.17
Volume
83,909
Market Cap
15.12M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
91,247
P/E Ratio
-1.85
Beta
1.04
1-Year Change
-75.47%
Shares Outstanding
57,063,623
Next Earnings Date
30 Aug 2022
What is your sentiment on ReNeuron?
or
Market is currently closed. Voting is open during market hours.

ReNeuron Group PLC Company Profile

ReNeuron Group PLC Company Profile

Employees
0

ReNeuron Group plc is a United Kingdom-based Stem Cell and Exosome Technologies company that utilizes its stem cell technologies to develop treatments for disease with unmet needs. The Company’s stem cell derived Exosome Technology platform offers a delivery mechanism for a variety of payloads, such as small interfering Ribonucleic Acid (siRNA), messenger RNA (mRNA), proteins, small molecules and genes. The Company has two clinical-stage stem cell therapy candidate assets, a Phase 2a human retinal progenitor cell (hRPC) therapy candidate in retinitis pigmentosa and a Phase 2b immortalized neural progenitor cell therapy candidate (CTX) in stroke. The Company through its induced pluripotent stem cell (iPSC) platform has the ability to make allogeneic tissue cells of choice and has the potential to produce exosomes with tissue specific targeting ability.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsBuySellSellStrong SellStrong Sell
SummaryNeutralStrong SellStrong SellStrong SellStrong Sell